Skip to main content
Clinical Trials/NCT03828513
NCT03828513
Active, not recruiting
Not Applicable

Can the Effects of High Flow Nasal Cannula Oxygenation on Postoperative Atelectasis be Evaluated With Lung Ultrasound: A Randomized Controlled Prospective Study

Kocaeli Derince Education and Research Hospital1 site in 1 country100 target enrollmentMarch 1, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Postoperative Atelectasis
Sponsor
Kocaeli Derince Education and Research Hospital
Enrollment
100
Locations
1
Primary Endpoint
Evaluation of postoperative atelectasis in bariatric surgery patients
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

Evaluate the effects of high-flow nasal oxygen therapy on atelectasis in the perioperative period by lung ultrasound (LUS) in bariatric surgery patients.

Detailed Description

In obese patients, lung compliance decreases by 25% and Functional Residual Capacity decreases by about one-third. As they consume about 25% more oxygen than non-obese individuals, postoperative pulmonary complications occur more commonly. POINT (Peri-Operative Insufflatory Nasal Therapy) provides humidified and heated high flow oxygen therapy in perioperative period. High-flow nasal oxygen (HFNO) facilitates oxygenation and ventilation of both the spontaneously breathing and apnoeic patient.High-flow nasal cannula oxygen came to prominence in anaesthesia when it was shown to prolong the time to oxygen desaturation in patients with a difficult airway. Lung ultrasonography (LUS) has been used more frequently in the diagnosis of pulmonary pathologies than chest radiography. This prospective observational study is to evaluate the effects of high-flow nasal oxygen therapy on atelectasis in the perioperative period by lung ultrasound (LUS) in bariatric surgery patients. Materials and Methods: Following the Ethics Committee approval and written informe consents, 100 adult bariatric surgery patients are include in this observational study. The patients are randomly distributed into two groups ; High Flow Nasal Cannula Oxygenation(HFNCO) made group(n:50); HFNCO not made group(n:50). HFNCO is start at a flow rate of 20 L/min with 100% oxygen in the preoperative period. It is titrate up to 50 L/min and increase to 80 L/min under general anesthesia until tracheal intubation. Atelectasis evaluation with lung ultrasound is performe and score in 6 different areas before and after HFNCO. Pulmonary function tests and blood gas parameters are compared.During the procedure, the patient's blood pressure, heart rate, oxygen saturation, any complications that may develop will be recorded.nduction of anesthesia; difficult airway management, difficult mask and / or difficult intubation incidence, Mallampati scores, the use of one of the difficult intubation techniques during intubation (such as FastTrack, videolaryngoscopy or fiberoptic intubation), perioperative mechanical ventilation parameters (ventilation mode, tidal volume, respiratory frequency, end of tidal CO2 (carbon dioxide) pressure, PEEP usage, SpO2 (saturation oxygen), airway peak pressure, urine volume, arterial blood gas parameters are recorded.Duration of operation, surgical method (laparotomy / laparoscopy), agents used in induction and postoperative analgesia, use of blood, blood product and vasopressor are recorded.

Registry
clinicaltrials.gov
Start Date
March 1, 2018
End Date
March 30, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Kocaeli Derince Education and Research Hospital
Responsible Party
Principal Investigator
Principal Investigator

EMİNE YURT

Principal Investigator

Kocaeli Derince Education and Research Hospital

Eligibility Criteria

Inclusion Criteria

  • Above 18 years;
  • Patients who have undergone obesity surgery;
  • ASA 2-3 patients;
  • Patients who have received written informed consent;

Exclusion Criteria

  • Patients under the age of 18;
  • Patients refusing to participate in the study;
  • Patients under emergency conditions;
  • Earlier laryngeal and tracheal surgery;
  • allergies to lidocaine;
  • Patients with FEV1 / FVC below 60%

Outcomes

Primary Outcomes

Evaluation of postoperative atelectasis in bariatric surgery patients

Time Frame: Up to 20 minutes in postoperative care unit

Postoperative atelectasis develops in patients undergoing laparoscopic bariatric surgery under anesthesia.After the operation a researcher will perform lung ultrasonography postoperative at minute 5. reseracher will detect 6 region of each lung totally 12 regions. the researcher will record the modified and original lung ultrasonography scores (LUS score) of the patients. LUS Score is a scoring system to eveluate atelectasis of lung and scores 1-3 points for each region (min score 0 max score 36)

Study Sites (1)

Loading locations...

Similar Trials